Smith, Salley & Associates Pfizer Inc Transaction History

Smith, Salley & Associates

  • $1.48 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024
SELL
$26.13 - $33.94 $268,538 - $348,801
-10,277 Reduced 46.28%
11,929 $343,000
Q3 2023

Oct 27, 2023
SELL
$32.09 - $37.51 $61,612 - $72,019
-1,920 Reduced 7.96%
22,206 $736,000
Q2 2023

Aug 04, 2023
SELL
$36.12 - $41.79 $50,712 - $58,673
-1,404 Reduced 5.5%
24,126 $884,000
Q1 2023

May 03, 2023
BUY
$39.39 - $51.28 $2,324 - $3,025
59 Added 0.23%
25,530 $1.04 Million
Q4 2022

Feb 03, 2023
BUY
$41.75 - $54.5 $12,525 - $16,350
300 Added 1.19%
25,471 $1.31 Million
Q3 2022

Nov 01, 2022
BUY
$43.76 - $53.42 $15,928 - $19,444
364 Added 1.47%
25,171 $1.1 Million
Q2 2022

Aug 01, 2022
SELL
$46.53 - $55.17 $47,507 - $56,328
-1,021 Reduced 3.95%
24,807 $1.3 Million
Q1 2022

May 10, 2022
SELL
$45.75 - $56.69 $51,514 - $63,832
-1,126 Reduced 4.18%
25,828 $1.34 Million
Q4 2021

Feb 10, 2022
SELL
$41.32 - $61.25 $11,652 - $17,272
-282 Reduced 1.04%
26,954 $1.59 Million
Q3 2021

Nov 05, 2021
SELL
$39.25 - $50.42 $38,857 - $49,915
-990 Reduced 3.51%
27,236 $1.17 Million
Q2 2021

Aug 09, 2021
BUY
$35.91 - $40.68 $23,844 - $27,011
664 Added 2.41%
28,226 $1.11 Million
Q1 2021

Apr 30, 2021
SELL
$33.49 - $37.77 $2.02 Million - $2.28 Million
-60,373 Reduced 68.66%
27,562 $999,000
Q4 2020

Jan 28, 2021
SELL
$33.47 - $42.56 $770,445 - $979,688
-23,019 Reduced 20.75%
87,935 $3.24 Million
Q3 2020

Nov 05, 2020
BUY
$31.75 - $37.25 $5,556 - $6,518
175 Added 0.16%
110,954 $4.07 Million
Q2 2020

Aug 04, 2020
BUY
$30.12 - $36.54 $150,178 - $182,188
4,986 Added 4.71%
110,779 $3.62 Million
Q1 2020

Apr 24, 2020
SELL
$27.03 - $38.62 $68,061 - $97,245
-2,518 Reduced 2.32%
105,793 $3.45 Million
Q4 2019

Jan 27, 2020
BUY
$32.92 - $37.36 $11,785 - $13,374
358 Added 0.33%
108,311 $4.24 Million
Q3 2019

Oct 30, 2019
BUY
$32.49 - $42.13 $157,479 - $204,204
4,847 Added 4.7%
107,953 $3.88 Million
Q2 2019

Jul 12, 2019
SELL
$36.98 - $41.52 $195,513 - $219,516
-5,287 Reduced 4.88%
103,106 $4.47 Million
Q1 2019

May 03, 2019
BUY
$37.5 - $41.2 $39,787 - $43,713
1,061 Added 0.99%
108,393 $4.6 Million
Q4 2018

Feb 05, 2019
SELL
$38.47 - $43.86 $174,846 - $199,343
-4,545 Reduced 4.06%
107,332 $4.69 Million
Q3 2018

Nov 06, 2018
SELL
$34.47 - $41.81 $134,639 - $163,309
-3,906 Reduced 3.37%
111,877 $4.93 Million
Q2 2018

Aug 10, 2018
SELL
$32.98 - $35.16 $21,074 - $22,467
-639 Reduced 0.55%
115,783 $4.2 Million
Q1 2018

May 09, 2018
BUY
$31.91 - $37.02 $37,302 - $43,276
1,169 Added 1.01%
116,422 $4.13 Million
Q4 2017

Feb 12, 2018
BUY
$33.26 - $35.29 $78,693 - $83,496
2,366 Added 2.1%
115,253 $4.18 Million
Q3 2017

Nov 02, 2017
BUY
$31.0 - $34.15 $3.5 Million - $3.86 Million
112,887
112,887 $4.03 Million

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.61B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Smith, Salley & Associates Portfolio

Follow Smith, Salley & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email